Chien-Hua Chen1,2,3, Cheng-Li Lin4,5, Chia-Hung Kao6,7,8. 1. Digestive Disease Center, Changbing Show-Chwan Memorial Hospital, Lukang Township, Changhua. 2. Digestive Disease Center, Show-Chwan Memorial Hospital, Changhua. 3. Department of Food Science and Technology, Hungkuang University, Taichung. 4. Management Office for Health Data, China Medical University Hospital, Taichung. 5. College of Medicine, College of Medicine, China Medical University, Taichung. 6. Graduate Institute of Biomedical Sciences and School of Medicine, College of Medicine, China Medical University, Taichung. 7. Department of Nuclear Medicine and PET Center, and Center of Augmented Intelligence in Healthcare, China Medical University Hospital, Taichung. 8. Department of Bioinformatics and Medical Engineering, Asia University, Taichung.
Abstract
BACKGROUND: To assess the subsequent risk of coronary heart disease (CHD) after the diagnosis of gallbladder polyp (GP). METHODS: We identified 2,815 GP patients aged ≥20 years from the Longitudinal Health Insurance Database between 2000 and 2011 and followed up the patients until the occurrence of CHD or the end of 2011, the patient would be censored in the occurrence of death, missed information, or withdrawal from the NHI. We selected 11,260 non-GP subjects by 4:1 randomly matching with the case cohort according to age, sex, and index date of GP diagnosis. RESULTS: GP cohort had greater risk of CHD than the control cohort [11.1 vs. 8.07 per 1,000 person-y, adjusted HR (aHR) of 1.28, 95% confidence interval (CI), 1.07-1.53] after adjusting age, sex, hypertension, diabetes, hyperlipidemia, gallstone, chronic obstructive pulmonary disease, and arrhythmia. The risk of CHD was significantly higher in the non-cholecystectomy cohort of GP patients than that in the non-GP cohort (10.9 vs. 8.07 per 1,000 person-y; aHR =1.28; 95% CI, 1.06-1.55). However, the risk of CHD contributed by GP was not significant after cholecystectomy (12.3 vs. 8.07 per 1,000 person-y; aHR =1.24; 95% CI, 0.83-1.85). Compared with the non-GP cohort without hypertension, the risk of CHD increased for GP cohort without (aHR =1.48; 95% CI, 1.18-1.87) or with hypertension (aHR =3.00; 95% CI, 2.30-3.92). Compared with the non-GP cohort without diabetes, the risk of CHD increased for GP cohort without diabetes (aHR =1.46; 95% CI, 1.21-1.76) or with diabetes (aHR =2.07; 95% CI, 1.35-3.18). Compared with the non-GP cohort without hyperlipidemia, the risk of CHD increased for GP cohort without (aHR =1.37; 95% CI, 1.10-1.70) or with hyperlipidemia (aHR =2.63; 95% CI, 2.01-3.44). Compared with the non-GP cohort without arrhythmia, the risk of CHD for GP patients increased without (aHR =1.40; 95% CI, 1.17-1.69) or with arrhythmia (aHR =2.88; 95% CI, 1.82-4.57). CONCLUSIONS: GP is associated with increased risk of developing CHD, and the risk increases with the presence of coexisting hypertension, diabetes, hyperlipidemia, or arrhythmia. 2019 Annals of Translational Medicine. All rights reserved.
BACKGROUND: To assess the subsequent risk of coronary heart disease (CHD) after the diagnosis of gallbladder polyp (GP). METHODS: We identified 2,815 GP patients aged ≥20 years from the Longitudinal Health Insurance Database between 2000 and 2011 and followed up the patients until the occurrence of CHD or the end of 2011, the patient would be censored in the occurrence of death, missed information, or withdrawal from the NHI. We selected 11,260 non-GP subjects by 4:1 randomly matching with the case cohort according to age, sex, and index date of GP diagnosis. RESULTS: GP cohort had greater risk of CHD than the control cohort [11.1 vs. 8.07 per 1,000 person-y, adjusted HR (aHR) of 1.28, 95% confidence interval (CI), 1.07-1.53] after adjusting age, sex, hypertension, diabetes, hyperlipidemia, gallstone, chronic obstructive pulmonary disease, and arrhythmia. The risk of CHD was significantly higher in the non-cholecystectomy cohort of GP patients than that in the non-GP cohort (10.9 vs. 8.07 per 1,000 person-y; aHR =1.28; 95% CI, 1.06-1.55). However, the risk of CHD contributed by GP was not significant after cholecystectomy (12.3 vs. 8.07 per 1,000 person-y; aHR =1.24; 95% CI, 0.83-1.85). Compared with the non-GP cohort without hypertension, the risk of CHD increased for GP cohort without (aHR =1.48; 95% CI, 1.18-1.87) or with hypertension (aHR =3.00; 95% CI, 2.30-3.92). Compared with the non-GP cohort without diabetes, the risk of CHD increased for GP cohort without diabetes (aHR =1.46; 95% CI, 1.21-1.76) or with diabetes (aHR =2.07; 95% CI, 1.35-3.18). Compared with the non-GP cohort without hyperlipidemia, the risk of CHD increased for GP cohort without (aHR =1.37; 95% CI, 1.10-1.70) or with hyperlipidemia (aHR =2.63; 95% CI, 2.01-3.44). Compared with the non-GP cohort without arrhythmia, the risk of CHD for GP patients increased without (aHR =1.40; 95% CI, 1.17-1.69) or with arrhythmia (aHR =2.88; 95% CI, 1.82-4.57). CONCLUSIONS: GP is associated with increased risk of developing CHD, and the risk increases with the presence of coexisting hypertension, diabetes, hyperlipidemia, or arrhythmia. 2019 Annals of Translational Medicine. All rights reserved.
Authors: P G McGovern; D R Jacobs; E Shahar; D K Arnett; A R Folsom; H Blackburn; R V Luepker Journal: Circulation Date: 2001-07-03 Impact factor: 29.690
Authors: Seon Hee Lim; Dong Hee Kim; Min Jung Park; Young Sun Kim; Chung Hyun Kim; Jung Yun Yim; Kyung Ran Cho; Sun Sin Kim; Seung Ho Choi; Nayoung Kim; Sang Heon Cho; Byung-Hee Oh Journal: Gut Liver Date: 2007-12-31 Impact factor: 4.519
Authors: Kornelia Kotseva; David Wood; Dirk De Bacquer; Guy De Backer; Lars Rydén; Catriona Jennings; Viveca Gyberg; Philippe Amouyel; Jan Bruthans; Almudena Castro Conde; Renata Cífková; Jaap W Deckers; Johan De Sutter; Mirza Dilic; Maryna Dolzhenko; Andrejs Erglis; Zlatko Fras; Dan Gaita; Nina Gotcheva; John Goudevenos; Peter Heuschmann; Aleksandras Laucevicius; Seppo Lehto; Dragan Lovic; Davor Miličić; David Moore; Evagoras Nicolaides; Raphael Oganov; Andrzej Pajak; Nana Pogosova; Zeljko Reiner; Martin Stagmo; Stefan Störk; Lale Tokgözoğlu; Dusko Vulic Journal: Eur J Prev Cardiol Date: 2015-02-16 Impact factor: 7.804
Authors: Vincent M Mellnick; Christine O Menias; Kumar Sandrasegaran; Amy K Hara; Ania Z Kielar; Elizabeth M Brunt; Maria B Majella Doyle; Nirvikar Dahiya; Khaled M Elsayes Journal: Radiographics Date: 2015 Mar-Apr Impact factor: 5.333
Authors: Robyn L McClelland; Neal W Jorgensen; Matthew Budoff; Michael J Blaha; Wendy S Post; Richard A Kronmal; Diane E Bild; Steven Shea; Kiang Liu; Karol E Watson; Aaron R Folsom; Amit Khera; Colby Ayers; Amir-Abbas Mahabadi; Nils Lehmann; Karl-Heinz Jöckel; Susanne Moebus; J Jeffrey Carr; Raimund Erbel; Gregory L Burke Journal: J Am Coll Cardiol Date: 2015-10-13 Impact factor: 24.094
Authors: Eun Jung Park; Hong Soo Lee; Sang Hwa Lee; Hye Jin Chun; Sun Young Kim; Yu Kyung Choi; Hee Jeong Ryu; Kyung Won Shim Journal: J Korean Med Sci Date: 2013-06-03 Impact factor: 2.153